Tonight the House is considering a long-overdue FY2022 funding bill that addresses critical aspects of cancer research, prevention and access to care.
Wednesday marks six months since the U.S. Food and Drug Administration (FDA) failed to meet its court-ordered deadline to rule on all e-cigarette and other new tobacco product manufacturers’ applications.
Antes del discurso del Presidente de los EE. UU. sobre el Estado de la Unión, la Red de Acción Contra el Cáncer de la Sociedad Americana Contra el Cáncer (ACS CAN) ofrece numerosas sugerencias de políticas sobre las formas en que la administración y el Congreso pueden lograr el ambicioso objetivo de la Iniciativa Nacional Misión contra el Cáncer (Cancer Moonshot) del Presidente.
Declaración de ACS CAN sobre la confirmación del comisionado de la FDA, el Dr. Robert Califf
The Food and Drug Administration (FDA) today authorized the marketing of two low-nicotine cigarettes as “modified risk tobacco products,” including one product that is menthol-flavored.
ACS CAN espera trabajar con el nuevo alcalde de la ciudad de Nueva York y la portavoz del consejo municipal en temas fundamentales de la salud.
The U.S. Food and Drug Administration (FDA) opposed public health groups’ request that the agency provide regular status reports to a U.S. District Judge and estimate the dates it expects to complete its review of applications for products that rank among the top 10 brands in market share.
The Food and Drug Administration announced this afternoon it has issued marketing orders for the first e-cigarette products authorized by the agency.
Washington, D.C.—Today the U.S. Food and Drug Administration (FDA) failed to meet its court-ordered deadline to rule on all e-cigarette and other tobacco product manufacturers’ applications to keep their harmful products on the market.
Washington, DC Mayor Bowser has signed legislation that prohibits the sale of some flavored tobacco products. ACS CAN appauds Mayor Bowser and asks a comprehensive approach.